Human colonocyte detoxification

Gut

Volumn 41, Issue 6, 1997, Pages 731-734

  Roediger, William E W ^a   Babidge, Wendy ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; OXIDOREDUCTASE;

ANTIOXIDANT ACTIVITY; COLITIS; DRUG DETOXIFICATION; ENZYME ACTIVITY; HUMAN; INTESTINE CELL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 0031451917     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.6.731     Document Type: Review

References (101)

1. Foster ASJ, Richter E, Lauterbach F, Hartmann F, eds. Intestinal metabolism of xenobiotics. Stuttgart: Gustav-Fischer Verlag, 1989.
2. Ilett KF, Tee LBG, Reeves PT, Minchin RF. Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmac Ther 1990;46:67-93.
3. Amdur MO, Doull J, Klaassen CD, eds. Toxicology: The basic science of poisons, 4th edn. New York: Pergamon Press, 1991.
4. Testa B. The metabolism of drugs and other xenobiotics. Biochemistry of redox reactions. London: Academic Press, 1995.
5. Oshinsky RJ, Strobel HW. Drug metabolism in rat colon: resolution of enzymatic constituents and characterization of activity. Mol Cell Biochem 1987; 75:31-60.
6. Pacifici GM, Franchi M, Gervasi PG, Longo V, Simplicio P, Temellini A, et al. Profile of drug-metabolizing enzymes in human ileum and colon. Pharmacology 1989;38:137-45.
7. Dipalma JA, Cunningham JT, Herrera JI, McCaffery TD, Wolf DC. Occupational and industrial toxin exposures and the gastrointestinal tract. Am J Gastroemerol 1991;86:1107-17.
8. Gonzalez FJ. Human cytochromes P-450: problems and prospects. TIPS 1992;13:346-52.
9. Ioannides I. Cytochromes P-450. Metabolic and toxicological aspects. Boca Raton: CRC Press, 1996.
10. Peters WHM, Kremers PG. Cytochromes P-450 in the intestinal mucosa of man. Biochem Pharmacol 1989;38:1535-8.
11. Peters WHM, Kock L, Nagengast FH, Kremers PG. Biotransformation in human intestine: critical low levels in the colon. Gut 1991;32:408-12.
12. McKay JA, Murray GI, Weaver RJ, Ewen SWB, Melvin WT, Burke MD. Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut 1993;34:1234-9.
13. Oshinsky RJ, Strobel HW. Drug metabolism in rat colon: resolution of enzymic constituents and characterization of activity. Mol Cell Biochem 1987;75:51-60.
14. Spigelman AD, Farmer KCR, Oliver S, Nugent KP, Bennett PN, Notarianni LJ, et al. Caffeine phenotyping of cytochrome P-4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis. Gut 1995;36:251-4.
15. Thies E, Siegers C-P. Metabolic activation and tumourigenesis. Prog Pharm Clin Pharm 1989;7:199-214.
16. Mayhew JW, Lombardi PE, Fawaz K, Goldin B, Foster EA, Goldberg M, et al. Increased oxidation of a chemical carcinogen, benzo(a)pyrene, by colon tissue specimens from patients with ulcerative colitis. Gastroenterology 1983;85:328-34.
17. Massaad L, De Waziers I, Ribrag U, Janot F, Beaune PH, Morizet J, et al. Comparison of mouse and human colon tumours with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res 1992;52: 6567-75.
18. Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF, Marchand LL. CYP1A1 Genetic polymorphisms and in situ colorectal cancer. Cancer Res 1994;54:3692-5.
19. Grisham MB, MacDermott RA, Deitch EA. Oxidant defense mechanisms in the human colon. Inflammation 1990;14:669-80.
20. Mandhar M, Balasubramanian KA. Antioxidant enzymes in rat gastrointestinal tract. Indian J Biochem Biophys 1986;23:276-8.
21. Baskar L, Balasubramanian KA. Effect of oxidant exposure on isolated rat colonocytes. Scand J Gastroenterol 1995;30:332-6.
22. Bhaskar L, Ramakrishna BS, Balasubramanian KA. Colonic mucosal antioxidant enzymes and lipid peroxidase levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995;10:140-3.
23. Siegers C-P, Böse-Younes H, Thies E, Hoppenkamps R, Younes M. Glutathione and GSH-dependent enzymes in the tumorous and non-tumorous mucosa of the human colon and rectum. J Cancer Res Clin Oncol 1984;107:238-41.
24. Jones DP. Glutathione distribution in natural products: absorption and tissue distribution. Methods Enzymol 1995;252:1-13.
25. Martensson J, Jain A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA 1990;87:1715-9.
26. Potter DW, Tran T-B. Apparent rates of glutathione turnover in rat tissues. Toxicol Appl Pharmacol 1993;120:186-93.
27. Batist G, Ishak KM, Hudson N, Demuys JM. Interindividual variation in phase II detoxification enzymes in normal human colon mucosa. Biochem Pharmacol 1988;37:4241-3.
28. Lash LH, Hagen TM, Jones DP. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. Proc Natl Acad Sci USA 1986;83: 4641-5.
29. Fields J, Keshavarzian A, Eiznhamer D, Frommel T, Winship D, Holmes E. Low levels of blood and colonie glutathione in ulcerative colitis [abstract]. Gastroenterology 1994;106:A680.
30. Peters WHM, Roelofs HMJ, Nagengast FM, Van Tongeren JHM. Human intestinal glutathione S-transferases. Biochem J 1989;257:471-6.
31. Clapper ML, Hoffman SJ, Tew KD. Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1991;1096:209-16.
32. Ranganathan S, Tew KD. Immunohistochemical localization of glutathione S-transferases a, μ and Ti in normal tissue and carcinomas from human colon. Carcinogenesis 1991;12:2383-7.
33. Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DE, et al. Glutathione S-transferase activity and glutathione S-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res 1995;55:2789-93.
34. Hertervig E, Nilsson A, Seidegard J. The expression of glutathione transferase μ in patients with inflammatory bowel disease. Scand J Gastroenterol 1994;29:729-35.
35. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF. Role of aromatic amine acetyl-transferase in human colorectal cancer. Arch Surg 1986;121:1259-61.
36. Roberts-Thomson IC, Ryan P, Khoo KK, Hart WJ, McMichael AJ, Butler RN. Diet, acetylator phenotype and risk of colorectal neoplasia. Lancet 1996;347:1372-4.
37. Sim E, Hickman D. Polymorphism in human N-acetyltransferase - the case of the missing allele. TIPS 1991;12:211-3.
38. Travis SPL, Jewell DP. Salicylates for ulcerative colitis - their mode of action. Pharm Ther 1994;63:135-61.
39. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 1988;948:37-66.
40. Minchin RF, Kadlubar FF, Ilett KF. Role of acetylation in colorectal cancer. Mutat Res 1993;290:35-42.
41. Pacifici GM, Bencini C, Rane A. Acetyltransferase in humans: development and tissue distribution. Pharmacology 1986;32:283-91.
42. Probst-Hensch M, Haile RW, Ingles SA, Longnecker MP, Han CY, Lin BK, et al. Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res 1995;55:2017-20.
43. Rodriguez JW, Kirlin WG, Ferguson RJ, Doll MA, Gray K, Rustan TD, et al. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch Toxicol 1993;67:445-52.
44. Kaderlik KR, Kadlubar FF. Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenctics 1995;5: S108-17.
45. Allgayer H, Ahnfelt NO, Kruis W, Klotz U, Frank-Holmberg K, Soderberg HNA, et al. Colonie N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease. Gastroenterology 1989;97:38-41.
46. Ireland A, Priddle JD, Jewell DP. Acetylation of 5-aminosalicylic acid by isolated human colonie epithelial cells. Clin Sci 1990;78:105-11.
47. Ireland A, Priddle JD, Jewell DP. Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell. Gut 1992;33:1343-7.
48. Babidge W, Millard S, Roediger W. Effect of sodium hydrogen sulfide and butyrate on acetylation of 5-aminosalicylic acid in isolated rat colonocytes. Med Sci Res 1994;22:219-20.
49. Boström H, Brömster D, Nordenstam H, Wengle B. On the occurrence of phenol and steroid sulphokinases in the human gastrointestinal tract. Scand J Gastroenterol 1968;3:369-75.
50. Lööf L, Wengle B. Enzymatic sulphation of bile salts in man. Scand J Gastroenterol 1979;14:513-19.
51. Dew MJ, Hawker PC, Nutter S, Allan RN. Human intestinal sulphation of lithocolate: a new site for bile acid metabolism. Life Sci 1980;27:317-23.
52. Cohen GM, Grafstrom RC, Gibby EM, Smith L, Autrup H, Harris CC. Metabolism of benzo(a)pyrene and 1-naphthol in cultured human tumorous and non tumorous colon. Cancer Res 1983;43:13125.
53. Ramakrishna BS, Gee D, Weiss A, Pannall P, Roberts-Thomson IC, Roediger WEW. Estimation of phenolic conjugation by colonic mucosa. J Clin Pathol 1989;42:620-3.
54. Pacifici GM, Eligi M, Giuliani L. (+) and (-) terbutoline are sulphated at a higher rate in human intestine than liver. Eur J Clin Pharmacol 1993;45:483-7.
55. Filipe MI. Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum. Gut 1969; 10:577-86.
56. Lauterbach F, Czekay R-P, Sund RB. Compartmentation of intestinal drug sulphoconjugation. Biochem Pharmacol 1993;46:1339-47.
57. Ramakrishna BS, Roberts-Thomson IC, Pannall PR, Roediger WEW. Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis. Gut 1991;32:46-9.
58. Roediger WEW. The role of sulphur metabolism and mercapto fatty acids in the aetiology of ulcerative colitis. In: Goebell H, Malchow H, Ewe K, Koelbel Ch, eds. Inflammatory bowel disease. Progress in basic research and clinical implications. Lancaster, UK: Kluwer Academic Publishers, 1991:17-27.
59. Raouf AH, Tsai HH, Parker N, Hoffman J, Walker RJ, Rhodes JM. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci 1992;83:623-6.
60. Corfield AP, Wagner SA, O'Donnell LJD, Durdey P, Mountford RA, Clamp JR. The role of enteric bacterial sialidase, siolate, O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin. Glycoconi J 1993; 10:72-81.
61. Yamori T, Kimura H, Stewart K, Ota DM, Cleary KR, Irimura T. Differential production of high molecular weight sulfated glyco-proteins in normal colonic mucosa, primary colon carcinoma and metastases. Cancer Res 1987;47:2741-7.
62. Corfield AP, Myerscough N, Gough M, Brockhausent I, Schauer R, Paraskeva C. Glycosylation patterns of mucin in colonie disease. Biochem Soc Trans 1995;23:840-5.
63. Jass JR, Robertson AM. Colorectal mucin histochemistry in health and disease: a critical review. Pathol Int 1994;44:487-504.
64. Chou H-C, Lang NP, Kadlubar FF. Metabolic activation of the N-hydroxyderivative of the carcinogen 4-aminobiphenyl by human tissue sulfotransferases. Carcinogenesis 1995;16:413-17.
65. Creveling CR, Thakker DR. O-, N- and S-methyltransferases. In: Kauffman FC, ed. Conjugation-deconjugation reactions in drug metabolism and toxicity. Berlin: Springer-Verlag, 1993:189-216.
66. Counts JL, Goodman JI. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 1995;83:13-15.
67. Dudeja PK, Foster ES, Brasitus TA. Synthesis of phosphatidylcholine by two distinct methyltransferases in rat colonic brush-border membranes: evidence for extrinsic and intrinsic membrane activities. Biochim Biophys Acta 196;875:493-500.
68. +-ATPase activity in rat colonic basolateral membranes. Biochem J 1988;251:215-22.
69. Weinshilboum R. Thiol S-methyltransferases, I: Biochemistry. In: Damani LA, ed. Sulphur-containing drugs and related compounds. Vol 2A. Chichester: Ellis Horwood, 1989:121-42.
70. Bremer J, Greenberg DM. Enzymic methylation of foreign sulfhydryl compounds. Biochim Biophys Acta 1961;46:217-24.
71. Weisiger RA, Pinkus LM, Jakoby WB. Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide. Biochem Pharmacol 1980;29:2885-7.
72. Weisiger RA, Jakoby WB. S-methylation: thiol S-methyltransferase. In: Jakoby WB, ed. Enzymatic basis of detoxication. Vol II. New York: Academic Press, 1980:131-40
73. Pacifici GM, Santerini S, Giuliani L, Rane A. Thiol methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther 1991;17:8-15.
74. Pacifici GM, Romiti P, Santerini S. Giuliani L. S-methyltransferases in human intestine: differential distribution of the microsomal thiol methyltransferase and cytosolic thiopurinc human bowel. Xenobiotica 1993;23:671-9.
75. Crooks PA. Interactions of sulphur-containing xenobiotics with S-adenosyl-L-methionine-dependent methyl transferases. In: Damani LA, ed. Sulphurcontaining drugs and related organic compounds. Chichester: Ellis Horwood, 1989:47-85.
76. Waring RH, Sturman SG, Smith MCG, Steventon GB, Heafield MTE, William AC. S-methylation in motor neuron disease and Parkinson's disease. Lancet 1989;ii:356-7.
77. Bradley H, Waring RH, Emery P. Reduced thiol methyl transferase activity in red blood cell membranes from patients with rheumatoid arthritis. J Rheumatol 1991;18:1787-9.
78. Pitcher MCL, Beatty ER, Harris RM, Waring RH, Cummings JH. Detoxification of luminal xenobiotics in ulcerative colitis [abstract]. Gastroenterology 1996;110:A1740.
79. Babidge WJ, Millard SH, Roediger WEW. Thiol methyltransferase activity in colonocytes and erythrocyte membranes. J Clin Pathol 1995;48:641-4.
80. Roediger WEW, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993;104:802-9.
81. Thiede C, Bayerdörffer E, Thiede H-M, Ochsenkühn T, Neubauer A. Quantification of the essential methyl group donor S-adenosyl-methionine in human colorectal mucosa of patients with inflammatory bowel disease (IBD) and colorectal adenomas (abstract). Gastroenterology 1995;108: A546.
82. Cravo M, Gloria L, De Sousa S, Chaves P, Pereira AD, Quina M, et al. Folate status, DNA methylation and colon cancer risk in inflammatory bowel disease. Clin Nutr 1995;14:50-3.
83. Weinshilboum R. Thiol S-methyltransferases, II: Pharmacogenetics. In: Damani LA, ed. Sulphur-containing drugs and related organic compounds. Chichester: Ellis Horwood, 1989:143-57.
84. Keith RA, Van Loon J, Wussow LF, Weinshilboum RM. Thiol methylation pharmacogenetic heritability of human erythrocyte thiol methyltransferase activity. Clin Pharmacol Ther 1983;34:521-8.
85. Waring RH and Emery P. Genetic factors predicting persistent disease: the role of defective enzyme systems. Baillieres Clin Rheumatol 1992;6:337-50.
86. Roediger WEW, Lawson MJ, Kwok V, Kerr Cirant A, Pannall PR. Colonic bicarbonate output as a test of disease activity in ulcerative colitis. J Clin Pathol 1984;37:704-7.
87. Charney AN, Wagner JD, Birnbaum GT, Johnstone JN. Functional role of carbonic anhydrase in intestinal electrolyte transport. Am J Physiol 1986;251:S682-7.
88. Spicer SS, Sens MA, Tashian RE. Immunocytochemical demonstration of carbonic anhydrase in human epithelial cells. J Histochem Cytochem 1982;30:864-73.
89. Gramlich TL, Hennigar RA, Spicer SS, Schulte A. Immunohistochemical localization of sodium-potassium-stimulated adenosine triphosphatase and carbonic anhydrase in human colon and colonic neoplasms. Arch Pathol Lab Med 1990;114:415-9.
90. Swenson ER. Distribution and functions of carbonic anhydrase in the gastrointestinal tract. In: Dodgson SJ, Tashian RE, Gros G, Carter ND, eds. The carbonic anhydrases. New York: Plenum Press, 1991:265-87.
91. Parsons DS. Role of anions and carbonic anhydrase in epithelia. Phil Trans R Soc Lond 1982;299:369-81.
92. Roediger WEW, Heyworth M, Willoughby P, Piris J, Moore A, Truelove SC. Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol 1982;35:323-6.
93. Caprilli R, Frieri G, Latella G, Vernia P, Santoro ML. Faecal excretion of bicarbonate in ulcerative colitis. Digestion 1986;35:136-42.
94. Roediger WEW. The colonie epithelium in ulcerative colitis: an energy deficiency disease. Lancet 1980;ii:712-5.
95. Latella G, Fonn R, Caprilli R, Frieri G, Plateroti M, Sambuy Y. Carbonic anhydrase 1. Expression in colonic mucosa of patients with ulcerative colitis [abstract]. Gastroenterology 1995;108:A858.
96. Maren TH, Sanyal G. The activity of sulfonamides and anions against the carbonic anhydrases of animals, plants and bacteria. Ann Rev Pharmacol Toxicol 1983;23:439-59.
97. MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978;17:135-50.
98. Clark DA, Thompson JE, Weiner LB, McMillan JA, Schneider AJ, Rokahr JE. Necrotizing enterocolitis: intraluminal biochemistry in human neonates and a rabbit model. Pediatr Res 1985;19:919-21.
99. Seo HG, Takata I, Nakamuro M, Tatsumi H, Suzuki K, Fujii J, Taniguchi N. Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats. Arch Biochem Biophys 1995;324:41-7.
100. Feil W, Lacy ER, Wong Y-MM, Burger D, Wenzl E, Starlinger M, Schiessel R. Rapid epithelial restitution of human and rabbit colonic mucosa. Gastroenterology 1989;97:685-701.
101. Chengelis CP, Neal RA. Studies of carbonyl sulfide toxicity: metabolism by carbonic anhydrase. Toxicol Appl Pharm 1980;55:198-202.